Skip to search formSkip to main contentSkip to account menu

amlexanox

Known as: 2-amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3b)pyridine-3-carboxylic acid, 5H-(1)Benzopyrano(2,3-b)pyridine-3-carboxylic acid, 2-amino-7-(1-methylethyl)-5-oxo-, Amoxanox 
An anti-aphthous ulcer drug. Amlexanox inhibits the synthesis and release of inflammatory mediators, including leukotrienes and histamine, from mast… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
OBJECTIVE To compare the effectiveness of two topical medications to reduce the pain and size of recurrent minor aphthous ulcers… 
2000
2000
Amlexanox binds S100A13 and inhibits the release of fibroblast growth factor 1 (FGF1). Because members of the S100 gene family… 
Review
1998
Review
1998
A 23‐year‐old woman developed allergic rhinitis in 1993. Her doctor prescribed for her Solfa (amlexanox 25 mg) and Lysozymen 90… 
1997
1997
Five percent Amlexanox oral paste is a novel treatment for aphthous ulcers. In 3 controlled clinical studies that evaluated 1,124… 
1997
1997
In order to explore candidates for proteins required in exocytosis, we used two anti-allergic drugs, amlexanox and cromolyn… 
1994
1994
Amlexanox (AMLX), an anti‐allergic agent, is available in Japan as Elics® opthalmic solution, Solfa® nasal douche and Solfa… 
1993
1993
Recently, we have reported that a nebulized solution of sodium cromoglycate (SCG) (Intal), a well known antiallergic agent, has… 
1986
1986
Amoxanox has potent antiallergic activity because it inhibits the release of chemical mediators such as histamine and…